Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Japan Medical Dynamic Marketing, Inc. ( (JP:7600) ).
Japan Medical Dynamic Marketing, Inc. has revised its consolidated earnings forecast for the fiscal year ending March 2026, citing increased sales from its new ‘Trivicta Hip Stem’ in the U.S. However, supply chain issues with outsourced knee joint products and rising costs are expected to impact profits negatively. The company is implementing strategies to improve efficiency and profitability, including a cost reduction project and direct shipping to Japan. Despite the forecast revision, the company maintains its annual dividend policy, emphasizing its commitment to shareholder returns.
The most recent analyst rating on (JP:7600) stock is a Hold with a Yen538.00 price target. To see the full list of analyst forecasts on Japan Medical Dynamic Marketing, Inc. stock, see the JP:7600 Stock Forecast page.
More about Japan Medical Dynamic Marketing, Inc.
Japan Medical Dynamic Marketing, Inc. operates in the medical industry, focusing on the development and distribution of orthopedic products, including hip and knee joint replacements. The company is expanding its market presence with products like the ‘Trivicta Hip Stem’ and is working on enhancing its supply chain and manufacturing capabilities.
Average Trading Volume: 100,344
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen13.61B
Find detailed analytics on 7600 stock on TipRanks’ Stock Analysis page.